$0.3698
-0.0173-4.47%
In chiusura: Nov 20, 4:00 PM EST
$0.3799
0.01012.73%
Post-mercato: 6:38 PM EST

The average analyst price target for Coherus Oncology is $6.89, 1713.6% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $1.05 to $12. The latest change came on Nov 10, 2026, when Guggenheim lowered its price target on Coherus Oncology from $10 to $8 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months